omeprazole sodium bicarbonate (Cipla USA Inc.)
Welcome to the PulseAid listing for the omeprazole sodium bicarbonate drug offered from Cipla USA Inc.. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
NON-PROPRIETARY NAME: | omeprazole sodium bicarbonate |
SUBSTANCE NAME: | OMEPRAZOLE; SODIUM BICARBONATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-01-30 |
END MARKETING DATE: | 0000-00-00 |
omeprazole sodium bicarbonate HUMAN PRESCRIPTION DRUG Details:
Item Description | omeprazole sodium bicarbonate from Cipla USA Inc. |
LABELER NAME: | Cipla USA Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; 1100(mg/1; mg/1) |
START MARKETING DATE: | 2017-01-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69097-913_9e07dedd-3aaa-4c0b-84fc-d98b65884558 |
PRODUCT NDC: | 69097-913 |
APPLICATION NUMBER: | ANDA207476 |
Other OMEPRAZOLE; SODIUM BICARBONATE Pharmaceutical Manufacturers / Labelers: